![Laurent Audoly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurent Audoly is the founder of Cytovia Therapeutics, Inc., Incendia Therapeutics, Inc. Current positions include Non-Executive Director at Ixaka Ltd. and Director at Cytovia, Inc. (Massachusetts).
Former roles include Chief Executive Officer at BE Therapeutics, Inc., President, Chief Executive Officer & Director at Kymera Therapeutics, Inc., Director-Research & Development Inflammation at MedImmune LLC, Biologics Research Site Lead at Merck & Co., Inc., Senior Research Scientist-Inflammation Department at Pfizer Inc., and Chief Scientific Officer at Pieris AG.
Education includes a doctorate from Vanderbilt University and an undergraduate degree from the University of South Florida.
| Sociétés | Poste | Début |
|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Fondateur | - |
Cytovia Holdings, Inc.
 Cytovia Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages on developing therapies to address unmet medical needs in oncology | Directeur/Membre du Conseil | - |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur Général | 01/06/2019 |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Directeur Général | 07/11/2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 11 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Health Technology |
Cytovia Holdings, Inc.
Cytovia Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages on developing therapies to address unmet medical needs in oncology | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
